Pharmazz

Willowbrook, IL · Founded 2010 · Privately Held (backing)

Operator of a pharmaceutical company intended to focus on discovering, acquiring, developing, and commercializing therapeutics. Pharmazz is based in Willowbrook, IL and was founded in 2010. It was valued at $588 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $45.8 million across 8 recorded rounds; the latest was a $10 million early-stage round in May 2025.

PMV mark · valuation
$588.0M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$45.8M
Last round
Early Stage VC
May 2025
What is Pharmazz worth?
$588.0MPrivateMarketView mark · Oct 2026

Valued at $588.0M at its later-stage round, Jun 2025. Nothing has traded since.

Free account
More of Pharmazz with a free account
  • ·Watch Pharmazz: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Pharmazz funding history

8 rounds
DateRoundRaisedPost-money
May 2025Early Stage VC$10.0M▮
Aug 2024Early Stage VC$7.5M▮
Oct 2023Seed Round$450K▮
Oct 2022Seed Round$2.3M▮
Apr 2021Early Stage VC$5.5M▮
Feb 2020Seed Round$1.4M▮
+ 2 earlier rounds · a free account shows the full history
Unlock post-money valuations

Membership and data by Private Market View

Pharmazz valuation

Pharmazz was valued at $588 million at its later-stage round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Pharmazz raised?

Pharmazz has raised $45.8 million across 8 recorded rounds since 2018. The largest was a $7.5 million early-stage round in Aug 2024; the most recent was a $10 million early-stage round in May 2025.

Pharmazz has filed 12 Form Ds with the SEC since 2018, most recently in Jun 2025 ($10 million sold to 1 investor).

How Pharmazz's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Pharmazz, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Pharmazz

What is Pharmazz worth?
Pharmazz is valued at $588.0M as of Oct 2026. Valued at $588.0M at its later-stage round, Jun 2025. Nothing has traded since.
How much has Pharmazz raised?
Pharmazz has raised $45.8M in total funding across 8 recorded rounds.
When did Pharmazz last raise?
Pharmazz last raised in May 2025 (Early Stage VC), raising $10.0M.